Psy176 - Significant Benefit and Relative Effectiveness Assessment of Orphan Medicinal Products in the European Union: A Comparative Analysis

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2750
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Regulation of Herbal (Traditional) Medicinal Products in the European Union

Pharmaceutical Regulatory Affairs: Open Access
2015English

Analysis of Orphan Drug Designations and Approvals in the United States and the European Union

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Legal Integration in the European Union and the Eurasian Economic Union: Comparative Analysis

International Organisations Research Journal
SociologyInternational RelationsFinanceEconomicsPolitical ScienceEconometrics
2019English

Comparative Analysis of Efficiency of Geoportals of Ukraine and the European Union

Zemleustrìj, kadastr ì monìtorìng zemelʹ
2018English

Comparative Advantages in Polish Export to the European Union — Food Products vs Selected Groups of Non-Food Products

Oeconomia Copernicana
2018English

Comparative Advantages in Polish Export to the European Union — Food Products vs Selected Groups of Non-Food Products

Oeconomia Copernicana
2018English

Ukraine and the European Union Industry: Comparative Statistical Analysis of Structural Advantages

Statistics of Ukraine
2017English

Comparative Studies of Biosimilar Medicinal Products

The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products
2019English

Which Democracy for a Union of States? A Comparative Perspective of the European Union

Global Policy
Planetary ChangeManagementInternational RelationsEconomicsGlobalPolitical SciencePolicyMonitoringLawEconometrics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy